News
Abigail Greene and Daniel Barson are married MD/PhD candidates at Yale School of Medicine with overlapping interests.
Neurodegenerative conditions pose their own particular challenges to doctors. Finding ways to treat and possibly prevent neural dysfunction is a full-time job for Yale researchers.
The laboratory of Angélique Bordey has made important progress in understanding neurodevelopmental disorders associated with epilepsy.
Nancy Brown discusses what makes Yale and Yale School of Medicine’s neuroscience departments so strong, and what the future holds.
Victims of stroke and traumatic neurological injury face a difficult problem: healing requires growing new connections. Researchers are working on ways to accelerate and supercharge the mind’s ability to mend.
One of Yale’s foremost neuroscientists, Amy Arnsten, talks about influences that brought her into the field, and about research areas into which she has unusual insight.
Yale researchers are exploring how sleep shapes memory by using advanced brain imaging and monitoring techniques.
Veronica Chiang has worked hard to compete for interesting positions, but she also credits her success to a certain amount of luck.
Illuminating the genetic and biological underpinnings of anxiety may lead to new therapies and clinical treatments, and vastly improve quality of life.
Research associated with neuroscience has long been a strength for Yale School of Medicine. This issue explores some of the questions currently animating the field, by looking at ongoing projects.
The traditional approach to inflammation is that it’s bad and should be suppressed, but recent findings offer a more nuanced view.
Researchers hope that the Colton Center for Autoimmunity at Yale will yield results over the next 10 years.
About a third of patients confirmed to have COVID-19 report a temporary loss of smell. Yale specialists describe why that might happen, and what can be done.
Ellen Hoffman is developing a microscope that will enable her to look into zebrafishes’ brains.
Researchers provide insights into the biological profiles of the underlying risk of substance use relapse, while treatment methods offer patients new options.
Virtual, augmented, and blended reality have clinical applications for treatment of the visually impaired. Now, those applications are making their way into the classroom at YSM.
The line between mental illness and genius has long been known to be razor-thin. Yale researchers stumbled upon evidence of this fragile boundary while researching auditory hallucinations in schizophrenia.
Health care leaders say that the United States of America is experiencing a mental health crisis; mental-illness-related deaths amount to the fifth-leading cause of mortality among Americans. Faculty and students at Yale School of Medicine look for answers.
